Close Menu

ScienceInsider reports that Raynard Kington, deputy director of the National Institutes of Health, is stepping down from his position in July and that he will become the president of Grinnell College in Iowa. Kington, having previously served as the director of the NIH’s behavioral sciences office, was named acting director of the NIH after Elias Zerhouni resigned in October 2008.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.